Fund 1 Investments’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,702
Closed -$971K 66
2024
Q1
$971K Buy
+6,702
New +$566K 0.1% 39
2023
Q3
Sell
-6,860
Closed -$434K 66
2023
Q2
$434K Buy
+6,860
New +$416K 0.18% 51
2023
Q1
Sell
-2,500
Closed -$145K 63
2022
Q4
$145K Buy
+2,500
New +$154K 0.07% 45

Other funds holding CDLX

Fund 1 Investments's CDLX Position: Q2 2024 in Review

Fund 1 Investments sold out of Cardlytics (CDLX) in Q2 2024, closing a stake of 6,702 shares — an estimated $971K sold.

Fund 1 Investments first reported a position in CDLX in Q4 2022 and held it in 3 quarters. The position peaked at $971K in Q1 2024. 127 funds tracked by Wall St. Rank hold CDLX as of Q2 2024.

  • Fund 1 Investments reported no remaining Cardlytics position as of Q2 2024 after selling out during the quarter.
  • Fund 1 Investments sold 6,702 Cardlytics shares in Q2 2024, an estimated $971K.
  • Fund 1 Investments first reported a position in Cardlytics in Q4 2022 and held it in 3 quarters.
  • Fund 1 Investments's Cardlytics position peaked at $971K in Q1 2024.
  • 127 funds tracked by Wall St. Rank held Cardlytics as of Q2 2024.

Based on Fund 1 Investments's 13F filing for Q2 2024, filed 14 Aug 2024.